IVF chains in India aren’t deterred by paltry things like probabilities. They’ve made IVF the new C-section—essentially, a revenue-generating procedure pushed before natural alternatives are even considered. All at 4X the cost of a C-section, or around Rs 2 lakh for a single cycle.

The result is a $1.4 billion IVF market in India—10 times the market for cataract surgery, the most common procedure worldwide.

Unsurprisingly, venture-capital and private-equity firms have swooped in for the kill. 

That this growth is coming at the cost of quality care is the real problem. 

Tune in.

Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.